For much of the cannabinoid supply market, the model has been simple: make the molecule, test the batch, sell the material.If the product meets basic specifications, passes third-party testing, and ca...

Over the last several years, we have spent a lot of time studying how cannabis retailers make purchasing decisions.Not just which products they buy, or how much they buy, but the entire sequence of ev...

For years, cannabis operators have accepted labeling inefficiencies as an unavoidable cost of doing business. Yet, many facilities still rely on fragmented, manual workflows that require employees to ...

Every conversation about cannabis risk follows the same script: Regulatory uncertainty, 280E, capital access, and maybe interstate commerce, depending on the room. None of that is wrong, and operators...